Patents by Inventor Robert Snow
Robert Snow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12637653Abstract: Methods for controlling a biological manufacturing system include directing a light beam to pass through a wall of a vessel containing a first fluid generated by the biological manufacturing system, measuring an angle of refraction of the light beam in the first fluid, the angle of refraction corresponding to an angle between a propagation direction of the light beam in the first fluid and a normal to an interface between the vessel wall and the first fluid, determining information about the first fluid based on the measured angle of refraction, and adjusting a parameter of the biological manufacturing system based on the information about the first fluid.Type: GrantFiled: October 21, 2020Date of Patent: May 26, 2026Assignee: GENZYME CORPORATIONInventors: Robert Snow, Joseph P. Kutzko, Xuezhen Kang
-
Patent number: 12435305Abstract: Provided herein are isolation processes and the associated hardware to allow fluid streams to be isolated from a sterilized system (e.g., a sterile process vessel) that contains a sterile process. The isolation processes described herein allow for continuous removal of fluid streams (e.g., waste streams, liquid containing recombinant therapeutic proteins) from a sterilized system (e.g., a biological manufacturing system), which provides for less manual manipulation of the sterilized system and a decreased risk of contaminating the sterilized system.Type: GrantFiled: September 21, 2020Date of Patent: October 7, 2025Assignee: Genzyme CorporationInventor: Robert Snow
-
Publication number: 20240268738Abstract: An automated evoked potential analysis apparatus for improved monitoring, detecting and identifying changes to a patient's physiological system, wherein the apparatus includes an input device for obtaining electrical potential data from the patient's physiological system after application of stimulation to a patient's nerve and a computing system for receiving and analyzing the electrical potential data. The computing system includes a processing circuit configured to: generate a plurality of evoked potential waveforms (EPs) based on the electrical potential data and calculate an ensemble average waveform (EA) of a subset of the plurality of EPs. The computing system is further configured to apply a mathematical wavelet transform to the resultant EA, attenuate noise components from the transformed EA, and apply an inverse transform to the transformed EA to generate a denoised EA.Type: ApplicationFiled: April 23, 2024Publication date: August 15, 2024Inventors: Gregg Johns, Richard Arthur O'Brien, Robert Snow
-
Patent number: 12048567Abstract: An automated evoked potential analysis apparatus for improved monitoring, detecting and identifying changes to a patient's physiological system is described. The apparatus includes an input device for obtaining electrical potential data from the patient's physiological system after application of stimulation to a patient's nerve and a computing system for receiving and analyzing the electrical potential data. The computing system includes a processing circuit configured to: generate a plurality of evoked potential waveforms (EPs) based on the electrical potential data, measure changes or trends in the generated EPs utilizing a sliding window of analysis, display incremental changes in waveforms between full subsets of EPs, and determine an alert vote for each subset, representative of changes to the physiological system generating the EPs.Type: GrantFiled: December 13, 2021Date of Patent: July 30, 2024Assignee: SafeOp Surgical, Inc.Inventors: Gregg Johns, Richard O'Brien, Robert Snow
-
Patent number: 11963775Abstract: A medical method of automatically improving signals received from a patient's physiological system can include delivering stimulation signals to a nerve pathway of a patient with electrical pulses via electrodes placed over the nerve pathway to generate a plurality of resultant electrical waveforms (EPs) based on a plurality of electrophysiological responses (ERs); recording the plurality of resultant EPs; generating an ensemble average waveform (EA), the generating comprising averaging a subset of the plurality of ERs; and denoising the EA, the denoising comprising applying a wavelet transform to the EA.Type: GrantFiled: March 21, 2018Date of Patent: April 23, 2024Assignee: SAFEOP SURGICAL, INC.Inventors: Gregg Johns, Richard Arthur O'Brien, Robert Snow
-
Patent number: 11920120Abstract: Provided herein are isolation processes and the associated hardware to allow fluid streams to be isolated from a sterilized system (e.g., a sterile process vessel) that contains a sterile process. The isolation processes described herein allow for continuous removal of fluid streams (e.g., waste streams, liquid containing recombinant therapeutic proteins) from a sterilized system (e.g., a biological manufacturing system), which provides for less manual manipulation of the sterilized system and a decreased risk of contaminating the sterilized system.Type: GrantFiled: November 24, 2021Date of Patent: March 5, 2024Assignee: Genzyme CorporationInventor: Robert Snow
-
Publication number: 20230371876Abstract: A method for determining a lowest stimulation threshold current level in a group of channels of a neuromonitoring device. The method includes stimulating tissue at a current level from a predetermined range of current levels as a sequence of pulses delivered at a frequency. The stimulating includes increasing the current level of each pulse in the sequence of pulses from an immediately preceding pulse by a first current increment. The method includes determining that a first evocation pulse from the sequence of pulses evokes a first muscular response. The method includes stimulating the tissue with a second evocation pulse from the sequence of pulses to evoke a second muscular response. The stimulating includes decreasing the frequency of the delivery of each pulse in the sequence of pulses and increasing the current level of each pulse in the sequence of pulses from the immediately preceding pulse by a second current increment.Type: ApplicationFiled: July 14, 2023Publication date: November 23, 2023Inventors: Richard A. O'Brien, Gregg Johns, Robert SNOW, James E. Gharib
-
Patent number: 11701047Abstract: A method for determining a lowest stimulation threshold current level in a group of channels of a neuromonitoring device. The method includes stimulating tissue at a current level from a predetermined range of current levels as a sequence of pulses delivered at a frequency. The stimulating includes increasing the current level of each pulse in the sequence of pulses from an immediately preceding pulse by a first current increment. The method includes determining that a first evocation pulse from the sequence of pulses evokes a first muscular response. The method includes stimulating the tissue with a second evocation pulse from the sequence of pulses to evoke a second muscular response. The stimulating includes decreasing the frequency of the delivery of each pulse in the sequence of pulses and increasing the current level of each pulse in the sequence of pulses from the immediately preceding pulse by a second current increment.Type: GrantFiled: June 15, 2018Date of Patent: July 18, 2023Assignee: Alphatec Spine, Inc.Inventors: Richard A. O'Brien, Gregg Johns, Robert Snow, James E. Gharib
-
Patent number: 11648401Abstract: A method of optimally placing spinal cord stimulator (SCS) leads includes acquiring components of somatosensory evoked potentials (SSEPs), compound action potentials and triggered EMG; analyzing the waveforms; and quantifying waveform features in a single display such that a surgeon can quickly and easily determine optimal placement (as it relates to laterality and level of placement on the spinal cord) of SCS leads in a patient under general anesthesia without additional expert help.Type: GrantFiled: November 13, 2017Date of Patent: May 16, 2023Assignee: SafeOp Surgical, Inc.Inventors: Richard O'Brien, Robert Snow
-
Patent number: 11510603Abstract: Devices and methods for stimulation and recording of muscle responses for determining degree of neuromuscular blockade, particularly relevant to elicitation of such responses in those under the influence of anesthesia. A system for estimating the degree of neuromuscular blockade includes at least one stimulating electrode, at least one recording electrode, a pulse generator for providing stimulation to a nerve through the stimulating electrode, and a computing device configured to: apply stimuli to the nerve according to a stimulation protocol, wherein the stimulation protocol provides a plurality of stimulation sequences that vary in frequency of pulses in the stimulation sequence, frequency of the stimulation sequences, number of pulses in the stimulation sequence, or all of the above; measure, by the recording electrode, electrical responses of a muscle; and estimate the degree of neuromuscular blockade based on changes in the electrical responses of the muscle during a stimulation sequence.Type: GrantFiled: December 18, 2020Date of Patent: November 29, 2022Assignee: SafeOp Surgical, Inc.Inventors: Robert Snow, Richard O'Brien
-
Publication number: 20220096022Abstract: An automated evoked potential analysis apparatus for improved monitoring, detecting and identifying changes to a patient's physiological system is described. The apparatus includes an input device for obtaining electrical potential data from the patient's physiological system after application of stimulation to a patient's nerve and a computing system for receiving and analyzing the electrical potential data. The computing system includes a processing circuit configured to: generate a plurality of evoked potential waveforms (EPs) based on the electrical potential data, measure changes or trends in the generated EPs utilizing a sliding window of analysis, display incremental changes in waveforms between full subsets of EPs, and determine an alert vote for each subset, representative of changes to the physiological system generating the EPs.Type: ApplicationFiled: December 13, 2021Publication date: March 31, 2022Inventors: Gregg Johns, Richard O'Brien, Robert Snow
-
Publication number: 20220081669Abstract: Provided herein are isolation processes and the associated hardware to allow fluid streams to be isolated from a sterilized system (e.g., a sterile process vessel) that contains a sterile process. The isolation processes described herein allow for continuous removal of fluid streams (e.g., waste streams, liquid containing recombinant therapeutic proteins) from a sterilized system (e.g., a biological manufacturing system), which provides for less manual manipulation of the sterilized system and a decreased risk of contaminating the sterilized system.Type: ApplicationFiled: November 24, 2021Publication date: March 17, 2022Applicant: Genzyme CorporationInventor: Robert Snow
-
Patent number: 11197640Abstract: An automated evoked potential analysis apparatus for improved monitoring, detecting and identifying changes to a patient's physiological system is described. The apparatus includes an input device for obtaining electrical potential data from the patient's physiological system after application of stimulation to a patient's nerve and a computing system for receiving and analyzing the electrical potential data. The computing system includes a processing circuit configured to: generate a plurality of evoked potential waveforms (EPs) based on the electrical potential data, measure changes or trends in the generated EPs utilizing a sliding window of analysis, display incremental changes in waveforms between full subsets of EPs, and determine an alert vote for each subset, representative of changes to the physiological system generating the EPs.Type: GrantFiled: May 3, 2016Date of Patent: December 14, 2021Assignee: SafeOp Surgical, Inc.Inventors: Gregg Johns, Richard O'Brien, Robert Snow
-
Publication number: 20210299381Abstract: A surgical device used for creating a surgical airway into the patient's trachea is disclosed. The device could enable a person or medical professional to make an incision through the patient tissue for creating the surgical airway in the patient's trachea. The device comprises a handle and a bolster. The handle having a longitudinal cavity at a second end for securely receiving and holding a blade. The bolster is securely and slidably positioned into a recess at the second end of the handle using a pair of latches. The bolster is configured to freely slide in and out of the handle for concealing and exposing the blade, thereby enabling a person or medical professional to make an incision proximate the patient's trachea for creating the surgical airway and allowing to simply insert a conventional tracheal tube via the incision to facilitate oxygenation and ventilation during emergency medical conditions.Type: ApplicationFiled: March 29, 2020Publication date: September 30, 2021Inventor: Robert Snow
-
Publication number: 20210115385Abstract: Methods for controlling a biological manufacturing system include directing a light beam to pass through a wall of a vessel containing a first fluid generated by the biological manufacturing system, measuring an angle of refraction of the light beam in the first fluid, the angle of refraction corresponding to an angle between a propagation direction of the light beam in the first fluid and a normal to an interface between the vessel wall and the first fluid, determining information about the first fluid based on the measured angle of refraction, and adjusting a parameter of the biological manufacturing system based on the information about the first fluid.Type: ApplicationFiled: October 21, 2020Publication date: April 22, 2021Inventors: Robert Snow, Joseph P. Kutzko, Xuezhen Kang
-
Publication number: 20210100490Abstract: Devices and methods for stimulation and recording of muscle responses for determining degree of neuromuscular blockade, particularly relevant to elicitation of such responses in those under the influence of anesthesia. A system for estimating the degree of neuromuscular blockade includes at least one stimulating electrode, at least one recording electrode, a pulse generator for providing stimulation to a nerve through the stimulating electrode, and a computing device configured to: apply stimuli to the nerve according to a stimulation protocol, wherein the stimulation protocol provides a plurality of stimulation sequences that vary in frequency of pulses in the stimulation sequence, frequency of the stimulation sequences, number of pulses in the stimulation sequence, or all of the above; measure, by the recording electrode, electrical responses of a muscle; and estimate the degree of neuromuscular blockade based on changes in the electrical responses of the muscle during a stimulation sequence.Type: ApplicationFiled: December 18, 2020Publication date: April 8, 2021Inventors: Robert Snow, Richard O'Brien
-
Publication number: 20210002601Abstract: Provided herein are isolation processes and the associated hardware to allow fluid streams to be isolated from a sterilized system (e.g., a sterile process vessel) that contains a sterile process. The isolation processes described herein allow for continuous removal of fluid streams (e.g., waste streams, liquid containing recombinant therapeutic proteins) from a sterilized system (e.g., a biological manufacturing system), which provides for less manual manipulation of the sterilized system and a decreased risk of contaminating the sterilized system.Type: ApplicationFiled: September 21, 2020Publication date: January 7, 2021Applicant: Genzyme CorporationInventor: Robert Snow
-
Patent number: 10869609Abstract: Devices and methods for stimulation and recording of muscle responses for determining degree of neuromuscular blockade, particularly relevant to elicitation of such responses in those under the influence of anesthesia. A system for estimating the degree of neuromuscular blockade includes at least one stimulating electrode, at least one recording electrode, a pulse generator for providing stimulation to a nerve through the stimulating electrode, and a computing device configured to: apply stimuli to the nerve according to a stimulation protocol, wherein the stimulation protocol provides a plurality of stimulation sequences that vary in frequency of pulses in the stimulation sequence, frequency of the stimulation sequences, number of pulses in the stimulation sequence, or all of the above; measure, by the recording electrode, electrical responses of a muscle; and estimate the degree of neuromuscular blockade based on changes in the electrical responses of the muscle during a stimulation sequence.Type: GrantFiled: November 25, 2015Date of Patent: December 22, 2020Assignee: SafeOp Surgical, Inc.Inventors: Robert Snow, Richard O'Brien
-
Patent number: 10267832Abstract: A power detection device for a facility monitoring system provides non-contact power detection in a power supply line for determining a powered up or energized state of equipment connected to the power supply line. The power detection device is adapted to be disposed in communication with a live power supply line without disconnecting or interrupting the power supply to the powered equipment. A hinged casing including a sensor circuit for detecting electrical current is frictionally engaged to the power supply line by closing the hinge and drawing opposed sides of the casing together. Sensor signals are aggregated and amplified such that an amplified signal above a threshold is indicative of a current flow sufficient to power the equipment and render a determination of an energized, or “equipment on” state. Conversely, the lack of a threshold signal indicates inactive equipment such that remedial measures may be commenced.Type: GrantFiled: March 28, 2017Date of Patent: April 23, 2019Assignee: AVTECH Software, Inc.Inventors: Richard Grundy, Robert Snow
-
Publication number: 20180360336Abstract: A method for determining a lowest stimulation threshold current level in a group of channels of a neuromonitoring device. The method includes stimulating tissue at a current level from a predetermined range of current levels as a sequence of pulses delivered at a frequency. The stimulating includes increasing the current level of each pulse in the sequence of pulses from an immediately preceding pulse by a first current increment. The method includes determining that a first evocation pulse from the sequence of pulses evokes a first muscular response. The method includes stimulating the tissue with a second evocation pulse from the sequence of pulses to evoke a second muscular response. The stimulating includes decreasing the frequency of the delivery of each pulse in the sequence of pulses and increasing the current level of each pulse in the sequence of pulses from the immediately preceding pulse by a second current increment.Type: ApplicationFiled: June 15, 2018Publication date: December 20, 2018Inventors: Richard A. O'Brien, Gregg Johns, Robert Snow, James E. Gharib